Description
-
- PNC-28 (20mg) is a peptide studied for its role in laboratory research on cancer biology, apoptosis, and tumor suppression.
- By targeting p53-related mechanisms, this peptide has been explored in research for its ability to selectively induce apoptosis in cancer cells.
- PNC-28 (20mg) has been investigated for its potential to disrupt tumor cell survival while minimizing effects on healthy cells in preclinical studies.
- Research has examined PNC-28 (20mg) in models focused on oncology, cell cycle regulation, and cancer pathway modulation.
- Additionally, PNC-28 (20mg) has been utilized in studies analyzing its impact on mitochondrial function and programmed cell death.
- Commonly used in preclinical research settings to assess its influence on cancer cell apoptosis and tumor biology processes.







There are no reviews yet.